Financials data is unavailable for this security.
View more
Year on year Active Biotech AB publ had revenues remain flat at 0.00, though the company grew net income from a loss of 58.37m to a smaller loss of 45.80m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -189.29% |
---|---|
Return on equity | -411.16% |
Return on investment | -322.63% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Active Biotech AB publ fell by 5.58m. Cash Flow from Financing totalled 40.16m or -- of revenues. In addition the company used 45.74m for operations while cash from investing was breakeven.
Cash flow per share | -0.1398 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0265 |
---|---|
Tangible book value per share | 0.026 |
More ▼
Balance sheet in SEKView more
Current ratio | 1.72 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2396 |
---|---|
Total debt/total capital | 0.1933 |
More ▼